Sidra Mahmood
Genomics Institute of the Novartis Research Foundation · 34 works · 2,135 citations · h-index 11
Top works
- The ALK Inhibitor Ceritinib Overcomes Crizotinib Resistance in Non–Small Cell Lung Cancer
- Acquired Resistance to Crizotinib from a Mutation in CD74 – ROS1
- PF-06463922, an ALK/ROS1 Inhibitor, Overcomes Resistance to First and Second Generation ALK Inhibitors in Preclinical Models
- Combined targeting of HER2 and VEGFR2 for effective treatment of HER2 -amplified breast cancer brain metastases
- Critique of medicinal conspicuousness of Parsley(Petroselinum crispum): a culinary herb of Mediterranean region.
- Review: an exposition of medicinal preponderance of Moringa oleifera (Lank.).
- Prescribing of bisphosphonates and antibiotics in Pakistan: challenges and opportunities for the future
- An Overview of Medicinal Importance of SWERTIA CHIRAYITA
- Assessment of active pharmaceutical ingredients in drug registration procedures in Pakistan: implications for the future
- Abstract 957: The ALK inhibitor LDK378 overcomes crizotinib resistance in non-small cell lung cancer
- Prevalence and treatment of neurological and psychiatric disorders among tertiary hospitals in Pakistan; findings and implications
- Comparative phytochemical, hepatoprotective and antioxidant activities of various samples of Swertia Chirayita collected from various cities of Pakistan.
- EVALUATION OF DRUG USE INDICATORS FOR NON-COMMUNICABLE DISEASES IN PAKISTAN.
- Evolution of resistance in ALK-positive patients treated with ALK tyrosine kinase inhibitors (TKIs).
- Future of Biotechnology in Pakistan
- Association of TGF-β2 levels in breast milk with severity of breast biopsy diagnosis
- Abstract 130: PF-06463922, a novel next generation ALK/ROS1 inhibitor, overcomes resistance to 1st and 2nd generation ALK inhibitors in pre-clinical models
- Trends in the prescribing of antipsychotic medicines in Pakistan: implications for the future
- Real time and accelerated stability studies of Tetanus toxoid manufactured in public sector facilities of Pakistan.
- COMPARATIVE BIOAVAILABILITY ANALYSIS OF ORAL ALENDRONATE SODIUM FORMULATIONS IN PAKISTAN.